Murielle Chauvel is a Technician in the Fungal Biology and Pathogencity Unit at Institut Pasteur since 2004. She is especially interested in the development of the functional genomics tools for C. albicans, such as the ORFeome, and the study of biofilm formation and morphogenesis in C. albicans.
She is also in charge of Hygiene and safety in the Unit.
Click to view graph
Connections
Click to view timeline
Timeline
Projects
Publications
Download-
2024β-1,6-Glucan plays a central role in the structure and remodeling of the bilaminate fungal cell wall., Elife 2024 Dec; 13(): .
-
2024Metabolic reprogramming during Candida albicans planktonic-biofilm transition is modulated by the transcription factors Zcf15 and Zcf26., PLoS Biol 2024 Jun; 22(6): e3002693.
-
2022A phylogenetically-restricted essential cell cycle progression factor in the human pathogen Candida albicans., Nat Commun 2022 Jul; 13(1): 4256.
-
2021Ethylzingerone, a Novel Compound with Antifungal Activity., Antimicrob Agents Chemother 2021 03; 65(4): .
-
2021Factors that influence bidirectional long-tract homozygosis due to double-strand break repair in Candida albicans., Genetics 2021 Mar; (): .
-
2020Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans., Front Microbiol 2020 ; 11(): 591140.
-
2018Generating genomic platforms to study Candida albicans pathogenesis., Nucleic Acids Res 2018 08; 46(14): 6935-6949.
-
2017Azole resistance in a mutant lacking the ABC transporter depends on TOR signaling, J. Biol. Chem. 2018 Jan;293(2):412-432.
-
2017Selective BET bromodomain inhibition as an antifungal therapeutic strategy, Nat Commun 2017 May;8:15482.
-
2014Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes, PLoS Pathog. 2014 Jun;10(6):e1004211.
-
+View full list of publications